Introduction to the Importance of Advanced Care
Every chronic neurodegenerative disease impacts the quality of life of people who become afflicted. Patients who suffer with this condition endure ongoing deterioration of their physical prowess as well as massive neurological impairments that compromise their motor abilities. This enormous burden on people with conditions of this type inspires the quest for Natural Cellular Regeneration that goes way beyond the scope of conventional medicine. Multiple Sclerosis (MS) is characterized by widespread injury to the central nervous system, the brain, and the spinal cord, through the disease process of demyelination of the myelin sheath of nerve fibers. This process leads to the slowing and disintegration of command signals. The impact of MS afflicts patients with chronic and debilitating fatigue, spasticity, and pain of the nervous system, along with sustained cognitive dysfunction. The unpredictable and erratic course of the disease with these MS flare-ups generates enormous anxiety and emotional burden for the patient and their family. The absence of satisfactory and affordable MS solutions that effectively promote the repair of damaged tissues is the reason for significant productivity losses and the high costs of treatment for the patient and society.
Understanding the Detailed Mechanism of the Multiple Sclerosis Disease
The most illuminating system to help understand the underlying pathology of Multiple Sclerosis is that of the immune system. Within the processes of Multiple Sclerosis, autoimmune activity perceives the myelin sheath as an external threat and therefore the body’s immune system initiates an immune response with Autoreactive T-cells breaching the blood-brain barrier. Following their entry to the central nervous system, these T-cells release pro-inflammatory cytokines, and the local microglia become activated. Further M1 type macrophages assault oligodendrocytes resulting in their apoptosis and subsequent necrosis, leading to a myelin sheath gap. Unmyelinated axons suffer a hostile environment resulting in block of the conduction of action potential. Subsequently, a chain of events leads to the exposure of the axon to ectonucleotides, leading to an environment that is toxic to the nerve. Reactive astrocytic cells migrate rapidly towards sites of injury and generate concentrated areas of glial scars. The scar tissue generated creates permanent plaques along the neural pathways. Continuous neural inflammation burns through Natural Cellular Regeneration resources and results in progression of axonal degeneration of a permanent kind.
Figure 1: Understanding the Detailed Mechanism of the Multiple Sclerosis Disease
Traditional Therapy and Their Shortcomings
Treatments currently employed by the medical field predominantly rely on the prescription of disease-modifying therapies since they seek to alter the course of Multiple Sclerosis. The principal focus of this group of therapies is to manage the effects of a hyperactive immune response. High doses of corticosteroids are prescribed to patients so as to rapidly manage neuroinflammation in the acute cases. The administration of drugs that target the immune response led to the progressive management since they impede the overall hyperactivity of lymphocytes. Monoclonal antibodies are designed to block certain immune cells so as to prevent their ability to cross the blood-brain barrier. The shortcomings of the classical therapies are many and considerable. Patients are left with a significant degree of vulnerability to a wide range of highly significant and serious opportunistic diseases. There are clinically serious viral diseases that result from complications of these therapies. Complications of the liver, heart, and the thyroid are serious and are also a common consequence of the prolonged pharmacotherapy. These therapies lack Natural Cellular Regeneration to rebuild lost myelin, as they only impair further degeneration and not the recovery of the lost function of the nervous system. Patients are left to suffer the appearance of new functional impairments to the nervous system, even when they comply to the prescribed therapies.
Mechanisms of the New Innovative Therapy
There is a new focus on these radical Structural Restorative Myelin repairs. In this field of medicine and research, the natural pathways of tissue regeneration and therapeutics are pioneered. The focus is to replace the lost oligodendrocytes in Multiple Sclerosis repair and to help the restorative processes of healing to aid the repair of the tissues through the use of the resident tissues and the use of the mesenchymal stem cells (MSCs) alongside the immune modulator of the tissues. These resident tissues are the neuroprotective tissues that are secreted by the stem cells modulating the immune environment. Signaling molecules stimulate the rapid growth of nearby neural progenitor cells. Chemical gradients guide the migrating cells to the site of demyelination. Once the progenitor cells localize to the demyelination site, they transform into myelin-generating cells. Natural Cellular Regeneration, therefore, supports the building of the myelination of axons. The sheath supports the active transport of impulses. The restoration of the sheath brings back normal functioning of the system. The localized naturally occurring Cellular Regeneration also minimizes the activation of the nearby cellular defense system of the nervous system and supports the growth of nervous system cells.
Figure 2: Comparisons of Traditional Therapy limitations and Natural Cellular Regeneration
The Future Trend of This Therapy in Thailand
The combination of the developing biotechnology and medical tourism in Southeast Asia gives the region an advantage. Thailand in particular has an appealing regulatory position for conducting clinical trials of regenerative medicine. The country has leading medical laboratories and clinical researchers who have supported the field of neurology, and there is ample government support for the conversion of research into practice. Compared to the slow and stiff regulatory systems of the West, Thailand’s rapid regulatory system enables quicker approvals for new cellular treatments. The affordability of treatment attracts foreign Multiple Sclerosis patients in need of advanced neurology care. Thailand has the best treatments and care in the world. It provides high-level treatments and care of the best quality that is not available in many European countries. The cares involve Restorative Cellular treatments and the best support in terms of actual rehabilitation. Thailand’s bright future in this industry places the country as the worldwide leader in Natural Cellular Regeneration therapies.